Effects of control interventions on Clostridium difficile infection in England: an observational study.
about
Risk factors for Clostridium difficile infection in surgical patients hospitalized in a tertiary hospital in Belgrade, Serbia: a case-control studyIncreasing incidence of Clostridium difficile ribotype 001 associated with severe course of the infection and previous fluoroquinolone use in the Czech Republic, 2015.Primary prevention of Clostridium difficile infections - how difficult can it be?[Individualized treatment strategies for Clostridium difficile infections].Comparison of Control of Clostridium difficile Infection in Six English Hospitals Using Whole-Genome Sequencing.Evidence-Based Approach to Clostridium difficile Infection.Levofloxacin Prophylaxis During Induction Therapy for Pediatric Acute Lymphoblastic Leukemia.Clostridium difficile infection: new approaches to prevention, non-antimicrobial treatment, and stewardship.Disease Burden of Clostridium difficile Infections in Adults, Hong Kong, China, 2006-2014.National antimicrobial stewardship and fluoroquinolone-resistant Clostridium difficile in China.Surveillance of antibiotic resistance among common Clostridium difficile ribotypes in Hong Kong.Why sensitive bacteria are resistant to hospital infection control.Interventions to reduce the incidence of hospital-onset Clostridium difficile infection: An agent-based modeling approach to evaluate clinical effectiveness in adult acute care hospitals.Impact of antimicrobial stewardship interventions on Clostridium difficile infection and clinical outcomes: segmented regression analyses.Whole-genome analysis reveals the evolution and transmission of an MDR DH/NAP11/106 Clostridium difficile clone in a paediatric hospital.Epidemiological aspects of healthcare-associated infections and microbial genomics.Opportunities to Improve Fluoroquinolone Prescribing in the United States for Adult Ambulatory Care Visits.Modeling the growth and decline of pathogen effective population size provides insight into epidemic dynamics and drivers of antimicrobial resistance.Two Distinct Patterns of Clostridium Difficile Diversity Across Europe Indicates Contrasting Routes of Spread.Clostridium difficile multidisciplinary team root cause analysis: impact on clinical care and circumvention of financial penalties posed by clinical commissioning groups, but at what cost?Root cause analysis for Clostridium difficile infections: is it time for change?Clostridium difficile: A bad bug goes into defensive mode.Genomic survey of Clostridium difficile reservoirs in the East of England implicates environmental contamination of wastewater treatment plants by clinical lineages.Molecular epidemiology of Clostridium difficile in two tertiary care hospitals in Shandong Province, China.Factors associated with an outbreak of hospital-onset, healthcare facility-associated Clostridium difficile infection (HO-HCFA CDI) in a Mexican tertiary care hospital: A case-control study.Time for a new resistance against antibiotics.Point-Counterpoint: Active Surveillance for Carriers of Toxigenic Clostridium difficile Should Be Performed To Guide Prevention EffortsBaxdela (Delafloxacin): A Novel Fluoroquinolone for the Treatment of Acute Bacterial Skin and Skin Structure Infections
P2860
Q37724361-F4715453-8FED-4212-AEDB-E4C294981172Q38691798-190CAA4B-E117-4B10-BA76-4809DBF68B6BQ38739075-3BB75515-18B4-4A56-A126-1802E93CD064Q40182314-C632B432-87AD-4CC7-9828-A06DE5ABD6FFQ40187460-C969E426-EAC6-4B70-9EDB-296B10396490Q40197781-43D1B937-B00A-4781-9109-9310B0B93675Q41987065-6D27F238-4E03-4E30-9D87-1F6F9022F67FQ41990887-0C062F50-A90A-40DE-8F7B-80131B3BB8C6Q42367460-D27183D6-2871-4CD2-95FF-ED30ADB78332Q42673152-7BE423BE-2912-4765-9B93-F7AACC99114DQ47103184-C86C2630-F5BF-441A-B82B-86B431D4E2E2Q47317915-137CF620-B3D4-404E-A556-96D091FB502FQ47372442-2AC50429-DAF1-4000-B4F4-66F784379FECQ47410726-06C04453-2A6E-45FB-861B-E69B0579106AQ47653532-8FB93EA1-986D-470B-9C3A-E2D7D21A7252Q48502848-F95701CC-E928-4F99-82F9-6F21745025ACQ49651505-017CBC39-BC0E-4140-98FB-9627509F9354Q50047129-FF37E797-14A2-4343-881E-9E774E3985EAQ52801942-12950870-C9BE-42D6-B5D1-25D90EEA828BQ54253861-4C624A5A-BAD2-4F67-BDA9-6AFD203CDD04Q54253865-249F8F18-36FB-4FC8-8902-15E19186FAD2Q54732607-23B88F1D-DC32-48D2-872C-55494A28FEEFQ54947135-17EBFDEC-EF09-45B7-9BE2-8E9F8385EFEAQ55100322-8CBE77E1-EABE-4A60-9286-25AA05E53100Q55258878-90F642FB-C5D0-4E01-89F9-FE7D21F968F2Q55265348-57FC49EC-E180-4578-A141-A5C5B941F9A6Q56934799-47DDC5E0-C73D-4983-8692-5D1C057895D2Q58574331-89790702-AEFD-4C65-81FC-8B63D823A97A
P2860
Effects of control interventions on Clostridium difficile infection in England: an observational study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effects of control interventio ...... gland: an observational study.
@en
Effects of control interventio ...... gland: an observational study.
@en-gb
Effects of control interventio ...... gland: an observational study.
@nl
type
label
Effects of control interventio ...... gland: an observational study.
@en
Effects of control interventio ...... gland: an observational study.
@en-gb
Effects of control interventio ...... gland: an observational study.
@nl
prefLabel
Effects of control interventio ...... gland: an observational study.
@en
Effects of control interventio ...... gland: an observational study.
@en-gb
Effects of control interventio ...... gland: an observational study.
@nl
P2093
P2860
P50
P1154
2-s2.0-85011357089
P1476
Effects of control interventio ...... gland: an observational study.
@en
P2093
A Sarah Walker
Alan P Johnson
Alison Vaughan
David Griffiths
David H Wyllie
Derrick W Crook
Diane M Citron
Ellie J C Goldstein
Jessica Martin
John M Finney
P2860
P304
P356
10.1016/S1473-3099(16)30514-X
P50
P5530
P577
2017-01-24T00:00:00Z
P6179
1074205511